These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21427013)

  • 1. Placenta analysis of prenatally diagnosed patients reveals early GAG storage in mucopolysaccharidoses II and VI.
    Baldo G; Matte U; Artigalas O; Schwartz IV; Burin MG; Ribeiro E; Horovitz D; Magalhaes TP; Elleder M; Giugliani R
    Mol Genet Metab; 2011 Jun; 103(2):197-8. PubMed ID: 21427013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay.
    Keulemans JL; Sinigerska I; Garritsen VH; Huijmans JG; Voznyi YV; van Diggelen OP; Kleijer WJ
    Prenat Diagn; 2002 Nov; 22(11):1016-21. PubMed ID: 12424767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for measuring disease-specific iduronic acid from the non-reducing end of glycosaminoglycan in mucopolysaccharidosis type II mice.
    Shimada Y; Wakabayashi T; Akiyama K; Hoshina H; Higuchi T; Kobayashi H; Eto Y; Ida H; Ohashi T
    Mol Genet Metab; 2016 Feb; 117(2):140-3. PubMed ID: 26051019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis and genetic counseling of mucopolysaccharidosis type II (Hunter syndrome).
    Chen CP; Lin SP; Tzen CY; Hwu WL; Chern SR; Chuang CK; Chiang SS; Wang W
    Genet Couns; 2007; 18(1):49-56. PubMed ID: 17515300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis.
    Lin HY; Lo YT; Wang TJ; Huang SF; Tu RY; Chen TL; Lin SP; Chuang CK
    Sci Rep; 2019 Jul; 9(1):10755. PubMed ID: 31341247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis type II: skeletal-muscle system involvement.
    Morini SR; Steiner CE; Gerson LB
    J Pediatr Orthop B; 2010 Jul; 19(4):313-7. PubMed ID: 20354449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid identification of San Filippo disease (MPS III).
    Kelly S; Schedlbauer L; Leikhim E
    Health Lab Sci; 1978 Jul; 15(3):123-7. PubMed ID: 151669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
    Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS
    Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucopolysaccharide storage diseases. II. Possibilities and problems in diagnostic typing as seen in patients in a pediatric hospital].
    Hässler A; Kirchner M; Friedrich H; Machill G
    Kinderarztl Prax; 1980 Sep; 48(9):455-70. PubMed ID: 6776332
    [No Abstract]   [Full Text] [Related]  

  • 12. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.
    Murgasova L; Jurovcik M; Jesina P; Malinova V; Bloomfield M; Zeman J; Magner M
    Int J Pediatr Otorhinolaryngol; 2020 Aug; 135():110137. PubMed ID: 32502916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of mucopolysaccharidosis by two-dimensional electrophoresis of amniotic fluid glycosaminoglycans.
    Mossman J; Patrick AD
    Prenat Diagn; 1982 Jul; 2(3):169-76. PubMed ID: 6815629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis].
    Huang YL; Li SY; Zhao XY; Fan LP; Lin WC; Zhou ZH; Cheng J; Liu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):510-4. PubMed ID: 22809603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots.
    Hein LK; Meikle PJ; Dean CJ; Bockmann MR; Auclair D; Hopwood JJ; Brooks DA
    Clin Chim Acta; 2005 Mar; 353(1-2):67-74. PubMed ID: 15698592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
    Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of donor chimerism to reduce the level of glycosaminoglycans following bone marrow transplantation in a murine model of mucopolysaccharidosis type II.
    Yokoi K; Akiyama K; Kaneshiro E; Higuchi T; Shimada Y; Kobayashi H; Akiyama M; Otsu M; Nakauchi H; Ohashi T; Ida H
    J Inherit Metab Dis; 2015 Mar; 38(2):333-40. PubMed ID: 25503568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrastructure of skin fibroblasts in storage diseases (mucopolysaccharidosis types IV and VI)].
    Bruskina VIa; Barer FS; Pavlova MN; Meerson EM
    Tsitol Genet; 1980; 14(5):21-6. PubMed ID: 6776669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.